Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BI 1744 CL dose-finding study in adults with asthma
2006-004829-29Phase 2Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Apr 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of olodaterol in asthma (5 arms), sponsored by Boehringer Ingelheim. Primary endpoints: Trough FEV1 response after 4 weeks of treatment and Bronchodilator efficacy. Started Apr 2007; status: completed.
02
Drugs
olodaterol
03
Conditions
asthma
Beyond the preview
Go deeper on 2006-004829-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-004829-29.